Kyle Piskel

Kyle Piskel is the Chief Financial Officer at Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Since joining Adaptive in 2015, Kyle has held various positions of ascending responsibility within finance and accounting, including Corporate Controller and Principal Accounting Officer. Prior to joining Adaptive, Kyle worked at Expedia Group and Ernst & Young, LLP.  Kyle is a Certified Public Accountant.